In addition, patients with positive PD-L1 expression have a poor prognosis [24], and necrosis-surrounding PD-L1-positive tumor cells trigger PD-1-related T cell apoptosis and are resistant to immune-induced tumor death [24]. The gene discussed is CD274; the disease is neoplasm.